This Research Topic delves into the forefront of strategies and technologies designed to improve long-term outcomes for ...

Mercy Health — Lourdes Hospital has officially restarted its structural heart program after Dr. Shankho Ganguli performed the ...

The recommendations are similar to those recently announced for TTVR, with the final NCD for T-TEER expected by July.

A Hoosier’s sudden aortic dissection led to a life-saving discovery: his sister was at risk, too. What seemed like a normal ...

Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.

TRILUMINATE's primary endpoint was a hierarchical composite of death from any cause or tricuspid valve surgery, ...

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Abbott (NYSE: ABT) today announced data demonstrating substantial, sustained improvements with its TriClip system.

Abbott presents positive TRILUMINATE Pivotal trial data, which demonstrates TriClip system's safety and effectiveness at the ACC.25.

A heartwarming reunion took place this morning between a Sioux City heart attack victim and the men who saved his life. Sleep ...

At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received the best available ...